How the OcuSurf Nanocore Delivery System Enables Sustained Release of Brinzolamide for Glaucoma Therapy
The Challenge: Glaucoma and the Limits of Conventional Brinzolamide Eye Drops Glaucoma is one of the leading causes of blindness among the elderly. It is
June 5, 2026
No Comments